These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2943770)

  • 81. The dexamethasone suppression test as a predictor of antidepressant response.
    Amsterdam JD; Winokur A; Bryant S; Larkin J; Rickels K
    Psychopharmacology (Berl); 1983; 80(1):43-5. PubMed ID: 6408669
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The dexamethasone suppression test in psychiatry.
    Joyce PR; Brinded PJ; Sellman D; Donald RA; Elder PA
    N Z Med J; 1987 Mar; 100(820):173-5. PubMed ID: 3452036
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evaluation of depression in a general hospital: utility and limitations of the dexamethasone suppression test.
    Thase ME; Brent DA; Neil JF; Horn TL
    Gen Hosp Psychiatry; 1985 Jan; 7(1):43-8. PubMed ID: 3967824
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J; Plocka M
    J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
    [TBL] [Abstract][Full Text] [Related]  

  • 85. CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients.
    Doran AR; Rubinow DR; Roy A; Pickar D
    Arch Gen Psychiatry; 1986 Apr; 43(4):365-9. PubMed ID: 2869743
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
    Birmaher B; Dahl RE; Ryan ND; Rabinovich H; Ambrosini P; al-Shabbout M; Novacenko H; Nelson B; Puig-Antich J
    Am J Psychiatry; 1992 Aug; 149(8):1040-5. PubMed ID: 1636803
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone.
    Maes M; Vandewoude M; Schotte C; Cosyns P
    Neuropsychobiology; 1989; 22(1):26-32. PubMed ID: 2639285
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dexamethasone suppression test and REM sleep in patients with major depressive disorder.
    Mendlewicz J; Kerkhofs M; Hoffmann G; Linkowski P
    Br J Psychiatry; 1984 Oct; 145():383-8. PubMed ID: 6487911
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinical investigations into antidepressive mechanisms. II. Dexamethasone suppression test predicts response to nomifensine or amitriptyline.
    Beckmann H; Holzmüller B; Fleckenstein P
    Acta Psychiatr Scand; 1984 Oct; 70(4):342-53. PubMed ID: 6388249
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A relationship between prolactin levels and dexamethasone suppression test results in major depressive disorder.
    Joyce PR; Donald RA; Livesey JH
    J Affect Disord; 1985; 8(2):191-5. PubMed ID: 3157731
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The effect of dexamethasone dosage upon plasma cortisol and dexamethasone during the DST.
    Wiedemann K; Holsboer F
    J Affect Disord; 1990 Jun; 19(2):133-7. PubMed ID: 2142700
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups.
    Mendlewicz J; Charles G; Franckson JM
    Br J Psychiatry; 1982 Nov; 141():464-70. PubMed ID: 7150882
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667
    [TBL] [Abstract][Full Text] [Related]  

  • 94. 4 p.m. baseline cortisol level as a predictor of DST results in depression.
    Weiler MA; Jobe TH; Nasr SJ; Pandey G; Altman EG
    J Clin Psychiatry; 1986 Feb; 47(2):60-2. PubMed ID: 3944064
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Chronic caffeine consumption and the dexamethasone suppression test in depression.
    Lee MA; Flegel P; Cameron OG; Greden JF
    Psychiatry Res; 1988 Apr; 24(1):61-5. PubMed ID: 3393618
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Plasma dexamethasone and the dexamethasone suppression test. Initial and follow-up tests in depressed patients.
    Johnson GF; Hunt GE; Caterson I
    J Affect Disord; 1988; 15(1):93-100. PubMed ID: 2970499
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hormonal changes in major depressive disorder.
    Kitamura T; Kano S; Shima S; Asai M
    Keio J Med; 1989 Mar; 38(1):40-52. PubMed ID: 2716217
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Dexamethasone suppression test in female patients with endogenous depression: determinations of plasma corticosterone, 11-deoxycorticosterone, 11-deoxycortisol, cortisol and cortisone.
    Holsboer F; Winter K; Dörr HG; Sippell WG
    Psychoneuroendocrinology; 1982; 7(4):329-38. PubMed ID: 7167629
    [No Abstract]   [Full Text] [Related]  

  • 99. Dexamethasone suppression test.
    Dam H
    Acta Psychiatr Scand Suppl; 1988; 345():38-44. PubMed ID: 3067539
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Situational depression and the dexamethasone suppression test.
    Lesser IM; Rubin RT; Finder E; Forster B; Poland RE
    Psychoneuroendocrinology; 1983; 8(4):441-5. PubMed ID: 6675036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.